239 related articles for article (PubMed ID: 9545728)
1. [Recurrent Plasmodium vivax malaria in spite of primaquine follow-up treatment].
Telgt DS; Mulder L; Dolmans WM
Ned Tijdschr Geneeskd; 1997 Sep; 141(37):1783-6. PubMed ID: 9545728
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
[TBL] [Abstract][Full Text] [Related]
3. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
Kitchener S; Nasveld P; Edstein MD
Am J Trop Med Hyg; 2007 Mar; 76(3):494-6. PubMed ID: 17360873
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine sensitivity of Plasmodium vivax in Thailand.
Looareesuwan S; Wilairatana P; Krudsood S; Treeprasertsuk S; Singhasivanon P; Bussaratid V; Chokjindachai W; Viriyavejakul P; Chalermrut K; Walsh D S; White J
Ann Trop Med Parasitol; 1999 Apr; 93(3):225-30. PubMed ID: 10562823
[TBL] [Abstract][Full Text] [Related]
6. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
[TBL] [Abstract][Full Text] [Related]
7. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
Yadav RS; Ghosh SK
J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium vivax relapses after 5 days of primaquine treatment, in some industrial complexes of India.
Dua VK; Sharma VP
Ann Trop Med Parasitol; 2001 Oct; 95(7):655-9. PubMed ID: 11784418
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic failure wtih chloroquine and primaquine in malaria by Plasmodium vivax].
Ocampo A; García-Bujalance S; Ladrón de Guevara C
Enferm Infecc Microbiol Clin; 1998 Dec; 16(10):490-1. PubMed ID: 9919001
[No Abstract] [Full Text] [Related]
10. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.
Dao NV; Cuong BT; Ngoa ND; Thuy le TT; The ND; Duy DN; Dai B; Thanh NX; Chavchich M; Rieckmann KH; Edstein MD
Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):534-9. PubMed ID: 17368694
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
Hamedi Y; Safa O; Zare S; Tan-ariya P; Kojima S; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):570-4. PubMed ID: 15689068
[TBL] [Abstract][Full Text] [Related]
12. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat.
Srivastava HC; Sharma SK; Bhatt RM; Sharma VP
Indian J Malariol; 1996 Dec; 33(4):173-9. PubMed ID: 9125831
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiological and therapeutic aspects of plasmodial infection from Plasmodium vivax].
Nicolas X; Granier H; Martin J; Klotz F
Med Trop (Mars); 2000; 60(4):402-8. PubMed ID: 11436600
[TBL] [Abstract][Full Text] [Related]
14. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy.
Goller JL; Jolley D; Ringwald P; Biggs BA
Am J Trop Med Hyg; 2007 Feb; 76(2):203-7. PubMed ID: 17297026
[TBL] [Abstract][Full Text] [Related]
15. A case of vivax malaria presenting with psychosis.
Tilluckdharry CC; Chadee DD; Doon R; Nehall J
West Indian Med J; 1996 Mar; 45(1):39-40. PubMed ID: 8693739
[TBL] [Abstract][Full Text] [Related]
16. Poor response to primaquine in two cases of Plasmodium vivax malaria from Guatemala.
Gascon J; Gomez Arce JE; Menendez C; Valls ME; Corachán M
Trop Geogr Med; 1994; 46(1):32-3. PubMed ID: 8165734
[TBL] [Abstract][Full Text] [Related]
17. Studies on a primaquine-tolerant strain of Plasmodium vivax from Brazil in Aotus and Saimiri monkeys.
Nayar JK; Baker RH; Knight JW; Sullivan JS; Morris CL; Richardson BB; Galland GG; Collins WE
J Parasitol; 1997 Aug; 83(4):739-45. PubMed ID: 9267419
[TBL] [Abstract][Full Text] [Related]
18. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
[TBL] [Abstract][Full Text] [Related]
19. Prevention of Plasmodium vivax malaria recurrence: efficacy of the standard total dose of primaquine administered over 3 days.
Carmona-Fonseca J; Maestre A
Acta Trop; 2009 Nov; 112(2):188-92. PubMed ID: 19653988
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India.
Dunne MW; Singh N; Shukla M; Valecha N; Bhattacharyya PC; Patel K; Mohapatra MK; Lakhani J; Devi CU; Adak T; Dev V; Yadav RS; Lele C; Patki K
Am J Trop Med Hyg; 2005 Dec; 73(6):1108-11. PubMed ID: 16354821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
